CapitalMidwestLogo.jpg
  • Home

  • Team

  • Portfolio

  • Legacy Investments

  • Press

    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2010-2014
  • More

    Use tab to navigate through the menu items.
    Milwaukee.png

    Press

    2015

     

    ProNAi Therapeutics Added to NASDAQ Biotechnology Index

    December 18, 2015

    ProNAi Therapeutics Appoints Dr. Keith Anderson and Dr. Gregg Smith to its Senior Management Team

    December 3, 2015

    LiquidCool to Launch New Technology at SC15

    November 3, 2015

    ProNAi Initiates 'Brighton' Phase II Trial of PNT2258 in Patients with Richter's Transformation

    October 29, 2015

    ProNAi Therapeutics Announces Closing of IPO and Full Exercise of the Underwriters' Option to Purchase Additional Shares

    July 21, 2015

    ProNAi Appoints Dr. Barbara Klencke as Chief Development Officer

    June 23, 2015

    ProNAi Appoints Dr. Nicole Onetto and Mr. Robert Pelzer to its Board of Directors

    June 18, 2015

    AdvancePath Academics, Inc. Announces the Acquisition of the Assets of SHW Enterprises, LLC dba ScholarCentric

    May 15, 2015

    ProNAi Strengthens Leadership Team; Opens Vancouver Corporate Headquarters

    June 16, 2015

    Winner of the IOT / M2M Innovation World Cup 2014/15 Healthcare Category [OnKöl]

    March 12, 2015

    ProNAi Initiates Phase II Trial of PNT2258 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

    January 7, 2015

    2020
    2019
    2018
    2017
    2016
    2015
    2010-2014
     

    Contact

    10556 N Port Washington Rd
    Ste 201
    Mequon, WI 53092

    (414) 453-4488

     

    ©2022 by Capital Midwest Fund